blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2134355

EP2134355 - NOVEL OPHTHALMIC COMPOSITIONS CONTAINING HUMAN RECOMBINANT LYSOZYME AND USE THEREOF FOR TREATING EYE CONDITIONS AND AS CONTACT LENS SOLUTIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.12.2012
Database last updated on 14.06.2024
Most recent event   Tooltip14.12.2012Application deemed to be withdrawnpublished on 16.01.2013  [2013/03]
Applicant(s)For all designated states
Saint Simeon Lda.
437 Route 208
Rhinebeck, NY 12572 / US
[2009/52]
Inventor(s)01 / FERRARI, Stefano
c/o Saint Simeon LDA 437 Route 308
Rhinebeck, NY 12572 / US
 [2009/52]
Representative(s)Wolff, Felix, et al
Kutzenberger Wolff & Partner
Waidmarkt 11
50676 Köln / DE
[N/P]
Former [2009/52]Wolff, Felix, et al
Patentanwälte Kutzenberger & Wolff Theodor-Heuss-Ring 23
50668 Köln / DE
Application number, filing date08731064.529.02.2008
[2009/52]
WO2008US55421
Priority number, dateUS20070892565P02.03.2007         Original published format: US 892565 P
[2009/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008109397
Date:12.09.2008
Language:EN
[2008/37]
Type: A2 Application without search report 
No.:EP2134355
Date:23.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application.
[2009/52]
Search report(s)International search report - published on:US13.11.2008
(Supplementary) European search report - dispatched on:EP14.12.2011
ClassificationIPC:A61K38/47, A61K31/00, C12N9/36
[2009/52]
CPC:
A61K38/47 (EP,US); A61K49/0043 (EP,US); A61P27/02 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/52]
TitleGerman:NEUE OPHTHALMISCHE ZUSAMMENSETZUNGEN MIT HUMANEM REKOMBINANTEM LYSOZYM UND IHRE VERWENDUNG ZUR BEHANDLUNG VON AUGENERKRANKUNGEN UND ALS KONTAKTLINSENLÖSUNGEN[2009/52]
English:NOVEL OPHTHALMIC COMPOSITIONS CONTAINING HUMAN RECOMBINANT LYSOZYME AND USE THEREOF FOR TREATING EYE CONDITIONS AND AS CONTACT LENS SOLUTIONS[2009/52]
French:NOUVELLES COMPOSITIONS OPHTALMIQUES CONTENANT UN LYSOZYME RECOMBINANT HUMAIN ET UTILISATION DE CELLES-CI POUR TRAITER LES AFFECTIONS DE L' IL ET COMME SOLUTION POUR LENTILLES DE CONTACT[2009/52]
Entry into regional phase02.10.2009National basic fee paid 
02.10.2009Search fee paid 
02.10.2009Designation fee(s) paid 
02.10.2009Examination fee paid 
Examination procedure02.10.2009Examination requested  [2009/52]
02.12.2009Amendment by applicant (claims and/or description)
13.07.2012Application deemed to be withdrawn, date of legal effect  [2013/03]
28.08.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/03]
Fees paidRenewal fee
01.03.2010Renewal fee patent year 03
28.02.2011Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
29.02.201205   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US6565861  (TIFFANY JOHN MICHAEL [GB], et al) [X] 1,3 * the whole document * * column 2, lines 20-59 * [Y] 1-8,12-14;
 [Y]WO0182893  (MOLNARNE KAHAN ILONA [HU]) [Y] 1-8,12-14 * the whole document * * example 1; claim - *;
 [Y]EP0275457  (EISAI CO LTD [JP]) [Y] 1-8,12-14 * column 3 * * the whole document *;
 [Y]WO8700200  (TAKEDA CHEMICAL INDUTRIES LTD [JP]) [Y] 1-8,12-14 * the whole document *;
 EP0181634  [ ] (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [ ] * the whole document *;
 [Y]EP0251730  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [Y] 1-8,12-14 * the whole document * * page 4, lines 43-50 *;
 [Y]CN1593651  ;
 [A]WO2007002145  (SAINT SIMEON LDA [US], et al) [A] 1-8,12-14;
 [Y]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2005, no. 79, Database accession no. 2005-770402, XP002665115 & CN1593651 A 20050316 (ZHANG H) [Y] 1-8,12-14 * abstract *
 [A]  - TSUBOTA K ET AL, "SERUM APPLICATION FOR THE TREATMENT OF OCULAR SURFACE DISORDERS", INTERNATIONAL OPHTHALMOGY CLINICS, LITTLE, BROWN AND CO., BOSTON, US, (20001001), vol. 40, no. 4, doi:10.1097/00004397-200010000-00009, ISSN 0020-8167, pages 113 - 122, XP009046112 [A] 1-8,12-14

DOI:   http://dx.doi.org/10.1097/00004397-200010000-00009
 [A]  - VALERIE A PROCTOR ET AL, "THE CHEMISTRY OF LYSOZYME AND ITS USE AS A FOOD PRESERVATIVE AND A PHARMACEUTICAL", CRC CRITICAL REVIEW IN FOOD SCIENCE & NUTRITION,, (19880101), vol. 26, no. 4, pages 359 - 395, XP001471089 [A] 1-8,12-14 * the whole document * * pages 383-386 *
International search[Y]US4961927  (KOGURE YOSHIO [JP]);
 [Y]US6949241  (MOLNARNE-KAHAN ILONA [HU]);
 [Y]US2004202687  (BABU M K MANOJ [US], et al)
 [Y]  - PETERS ET AL., "The Human Lysozyme Gene", EUR. J. BIOCHEM., (1989), vol. 182, no. 3, pages 507 - 516, XP008118656

DOI:   http://dx.doi.org/10.1111/j.1432-1033.1989.tb14857.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.